Although tech news in the Windy City was on the quieter side last week, a few companies managed to raise capital. Backed with fresh funding, these tech companies are innovating the biotech and software industries. Catch up on the latest with the Built In Chicago Weekly Refresh.
IManage received a strategic growth investment. Chicago-based iManage uses artificial intelligence to help accounting, finance and legal teams increase productivity and optimize their workflows. The dollar amount for this investment, which came from Bain Capital Tech Opportunities, was not disclosed. Chicago-based iManage is also hiring for 15 roles spanning sales, engineering, finance and operations. [Mergers&Acquisitions]
Chicago Tech Quote of the Week
“The field of cell therapy has been limited by the lack of tools to isolate and expand tumor-reactive cells that are efficacious against solid tumors. This funding enables further optimization and validation of our proprietary technology platform and expansion of our team to support our mission to deliver curative therapies for all individuals living with cancer.” — Shana Kelley, founder and CTO of CTRL Therapeutics
CTRL Therapeutics got $10M. Having recently launched, the Chicago-based biotech company is developing a cell therapy solution for solid tumors by taking circulating tumor-reactive lymphocytes from blood. According to CTRL, this next-generation solution may allow for broader patient access and allow patients to avoid expensive surgeries. The $10 million seed round was led by General Catalyst. [PR Newswire]
Project44 hired a new chief people officer. Renee Mauldin joined project44 as the company’s new CPO. She will spearhead all people initiatives. Mauldin previously worked as a CPO at Nubank, where she helped the company grow from 100 employees to over 5,000 people. Project44, which is currently hiring for a handful of positions, is a supply chain visibility platform. [PR Newswire]
